General Information regarding the listing of the fund CHAE
Document6 pages, a scan, not read yetOpen DFM’s file
Page 1
شیمیرا كابیتال لیمیتد.
ُمربعة سوق أبوظبي العالمي، مبنى المقام، طابق رقم 35، مكتب رقم 3502، جزیرة الماریة، أبوظبي ، الإمارات العربیة المتحدة Chimera Capital Limited
Office 3502, 35th Floor, Al Maqam Tower, ADGM Square, Al Maryah Island, Abu Dhabi, UAE chimerainvestment.com
Name of Fund Chimera S&P UAE UCITS ETF - Share Class A - Accumulating Fund ISIN IE00BKDMN692
Name ofManagementCompany
FundRock Management Company S.A Regulatory
AuthorityCentral Bank of IrelandCustodian The Bank of New York Mellon SA / NV, Dublin Branch
Administrator BNY Mellon Fund Services (Ireland) Designated Activity Company Legal Advisor Arthur Cox
InvestmentManagerChimera Capital LimitedAuditor Deloitte Ireland LLPAuthorizedParticipants*§ Arqaam Securities LLC
§ BH Mubasher Financial Services PJSC § EFG Hermes UAE LLC
§ International Securities LLC Liquidity
Providers*FundObjective
Chimera S&P UAE UCITS ETF - Share Class A - Accumulating is an exchange traded fund that seeks to provide investors with a total return, taking into account capital and income returns, which reflects the return of an equity index called the S&P UAE BMI Liquid 20/35 Capped Index. The fund allows a single access point to the United Arab Emirates equity markets. The dividends received by the fund will be reinvested
FundInvestmentPolicy
The principal investment strategy used by a Fund is disclosed in its investment objective.
Typically, a Fund will pursue either a replicating strategy or a representative sampling strategy.
Irrespective of the strategy pursued, there are circumstances where it may not be possible or practicable for a Fund to hold Index constituents (for example where there is a period of illiquidity in an Index constituent). Also, as a result of market movements between periodic Index rebalancing the weighting of an Index, a constituent may exceed the regulatory investment restrictions. In such circumstances the Investment Manager will seek to reduce the Fund’s exposure to the relevant constituent to seek to return the Fund to within the permitted limits. The Investment Manager may achieve this through representative sampling or by
Page 2
شیمیرا كابیتال لیمیتد.
ُمربعة سوق أبوظبي العالمي، مبنى المقام، طابق رقم 35، مكتب رقم 3502، جزیرة الماریة، أبوظبي ، الإمارات العربیة المتحدة Chimera Capital Limited
Office 3502, 35th Floor, Al Maqam Tower, ADGM Square, Al Maryah Island, Abu Dhabi, UAE chimerainvestment.com
holding a security which is not an Index constituent but which the Investment Manager otherwise believes will help track the performance of the relevant Index.
The Investment Manager may, on behalf of a Fund and subject to the conditions and within the limits laid down by the Central Bank, employ techniques and instruments relating to transferable securities and money market instruments for efficient portfolio management purposes in accordance with the investment strategy of the Fund.
For further information kindly refer to the Prospectus (page 17 - 23) section 4 under the heading “Investment Objectives and Policies “, and the Supplement (page 4 - 5) under the heading “Investment Policy”.
Index Provider S&P Dow Jones Indices LLCList of IndexConstituents*
List of constituents of the S&P UAE BMI Liquid 20/35 Capped Index No COMPANY MARKET INDEX WEIGHT
1 ABU DHABI NATIONAL OIL COMPANY FORDISTRIBUTION PJSC ADX 5.40%
2 Abu Dhabi Commercial Bank ADX 8.60% 3 Abu Dhabi Islamic Bank ADX 2.20% 4 ALDAR Properties ADX 7.10%
5 Dana Gas PJSC ADX 1.20%
6 Emirates Telecommunications Group ADX 17.30% 7 Eshraq Investments PJSC ADX 0.20%
8 FIRST ABU DHABI BANK ADX 31.90%9 Air Arabia DFM 1.40%10 Amanat Holding PJSC DFM 0.50%
11 DAMAC Properties Dubai Co PJSC DFM 1.00% 12 Deyaar Development Company DFM 0.20% 13 Dubai Financial Market DFM 0.80% 14 Dubai Investments (DI) DFM 1.50% 15 Dubai Islamic Bank DFM 4.30%
Page 3
شیمیرا كابیتال لیمیتد.
ُمربعة سوق أبوظبي العالمي، مبنى المقام، طابق رقم 35، مكتب رقم 3502، جزیرة الماریة، أبوظبي ، الإمارات العربیة المتحدة Chimera Capital Limited
Office 3502, 35th Floor, Al Maqam Tower, ADGM Square, Al Maryah Island, Abu Dhabi, UAE chimerainvestment.com
16 DXB Entertainment PJSC DFM 0.10%17 EMAAR DEVELOPMENT PJSC DFM 1.10%
18 Emaar Malls Group DFM 1.60% 19 Emaar Properties DFM 6.20%
20 Emirates NBD PJSC DFM 6.90% 21 Union Properties DFM 0.30%
22 SHUAA Capital PSC DFM 0.20%This information is based as of end of day, 2nd March 2021Financial Yearof the Fund
The annual accounts shall be made up from the 1st of January to the 31st of December in each year, except for the Fund’s first year annual accounts which shall begin from its date of authorization until 31st December 2021. The unaudited half-yearly accounts shall be made up to 30 June in each year and the initial half-yearly accounts shall be made up to 30 June 2021.
RegulatoryStructure
An Irish collective asset-management vehicle with registered number C188915 and established as an umbrella fund with segregated liability between sub-funds pursuant to the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011, as amended.
DividendPolicyDividends will be reinvestedShariahCompliantNoPortfolioCompositionPlease click on the link:
https://www.chimerainvestment.com/Website/en/capital.html Net Asset
Value (NAV)FrequencyDailyIndicative NetAsset Value(INAV)FrequencyLive during the trading session
Page 4
شیمیرا كابیتال لیمیتد.
ُمربعة سوق أبوظبي العالمي، مبنى المقام، طابق رقم 35، مكتب رقم 3502، جزیرة الماریة، أبوظبي ، الإمارات العربیة المتحدة Chimera Capital Limited
Office 3502, 35th Floor, Al Maqam Tower, ADGM Square, Al Maryah Island, Abu Dhabi, UAE chimerainvestment.com
Fund’s Capital Minimum Size: 500,000 UnitsMaximum: N/ANumber ofUnitsMinimum Size: 500,000 UnitsMaximum: N/AProcedures forSubscription& redemptionof unitsPhysical Inkind through the Authorised Participants
Kindly refer to the Prospectus (page 36 - 48) section 9 under the heading “Applications for Subscription and Redemption “
Conditionsthat may leadto theliquidation ofthe ETF
On a winding up or if all of the shares in any Fund are to be redeemed, the assets available for distribution (after satisfaction of creditors' claims) shall be distributed pro rata to the holders of the shares in proportion to the number of the shares held in that Fund. The balance of any assets of the ICAV then remaining that are not attributable to any particular Fund shall be apportioned among the Funds pro rata to the Net Asset Value of each Fund immediately prior to any distribution to Shareholders and shall be distributed among the Shareholders of each Fund pro rata to the number of shares in that Fund held by them. With the authority of an ordinary resolution of the Shareholders, the ICAV may make distributions in specie to Shareholders or to any individual Shareholder who so consents. At the request of any Shareholder the ICAV shall arrange the sale of such assets at the expense of such Shareholder and without any liability on the part of the ICAV, the Manager, the Administrator or the Investment Manager if the proceeds of sale of any asset are less than the value of the assets at the time at which it was distributed in specie. The transaction costs incurred in the disposal of such investments shall be borne by the Shareholder. As at the date of the Prospectus it is anticipated that all other costs associated with a winding up will be paid by the Investment Manager. The Subscriber Shares do not entitle the holders to participate in the dividends or net assets of any Fund.
For further information kindly refer to the Prospectus (page 82 - 83) section 16.7 under the heading “Termination”.
Expenses andFees
The ICAV shall pay to the Manager out of the Fund’s assets an annual Management Fee of 1% of the Fund’s daily Net Asset Value. The Manager will retain a fee for its remuneration (in respect of the provision of management services and such other services as have been agreed with the Manager, including the provision of company secretarial services, MLRO services and the maintenance of the ICAV’s beneficial ownership register) out of the Management Fee (the “Manager’s Fee”) and any reasonable and properly vouched expenses (the “Manager’s Expenses”) as well as extraordinary expenses outside the ordinary course of business where agreed in advance with the ICAV (“Extraordinary Expenses”) and shall further discharge all fees and expenses related to the Fund, as detailed in the Prospectus under the section headed “Fees and Expenses”, out of the Management Fee.
Page 5
شیمیرا كابیتال لیمیتد.
ُمربعة سوق أبوظبي العالمي، مبنى المقام، طابق رقم 35، مكتب رقم 3502، جزیرة الماریة، أبوظبي ، الإمارات العربیة المتحدة Chimera Capital Limited
Office 3502, 35th Floor, Al Maqam Tower, ADGM Square, Al Maryah Island, Abu Dhabi, UAE chimerainvestment.com
The Manager shall pay the remainder of the Management Fee, if any, to the Investment Manager in consideration of the services provided by the Investment Manager pursuant to the Investment Management Agreement and Global Distribution Agreement. In the event that the Fund’s expenses as outlined in the Section 10.2 of the Prospectus exceed the Management Fee, the Investment Manager shall discharge any such expenses out of its own assets.
The Fund may charge rebalancing costs (such as brokerage, exchange trading costs or other fees, charges, interest, taxes or levies incurred in connection with acquiring or disposing of investments) to the capital of the Fund. This will have the effect of lowering the capital value of a Shareholders investment.
For further information kindly refer to the Prospectus (page 49 - 50) section 10 under the heading “Fees, costs and expenses”.
Currency United Arab Emirates Dirham (AED)
Price Per Unit NAV on the listing Date Initial Offer
Period (IOP)PriceAED 3.67ReportsAvailable forUnit holders§ Fund Factsheet (Monthly)
§ Annual audited financial reports and unaudited Half-Yearly financial reports § Any other additional reports as determined by the investment manager from time to time.
Funds Addressand Website3-4 Upper Pembroke St, Dublin 2, Irelandwww.chimerainvestment.comETF UnitsHolders Rights
There are no rights of pre-emption upon the issue of shares in the ICAV. The Subscriber Shares do not participate in the assets of any Fund. Each of the shares entitles the Shareholder to participate equally on a pro rata basis in the dividends and net assets of a Fund attributable to the relevant Class in respect of which they are issued, save in the case of dividends declared prior to becoming a Shareholder. The Subscriber Shares' entitlement is limited to the amount subscribed and accrued interest thereon.
The Directors reserve the right to predesignate any Class of shares from time to time, provided that shareholders in that Class shall first have been notified by the ICAV thirty calendar days in advance that the shares will be predesignated and shall have been given the opportunity to
Page 6
No text on this page.